Functional interaction of NMDA and group I metabotropic glutamate receptors in negatively reinforced learning in rats

Psychopharmacology

Volumn 185, Issue 1, 2006, Pages 58-65

  Gravius, A ^a   Pietraszek, M ^a,b   Schmidt, W J ^c   Danysz, W ^a  

^a MERZ PHARMACEUTICALS GMBH   (Germany)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acquisition; Fear potentiated startle; mGlu1 receptor antagonist; mGlu5 receptor antagonist; NMDA receptor antagonist; Passive avoidance

Indexed keywords

(3 ETHYL 2 METHYLQUINOLIN 6 YL)(4 METHOXYCYCLOHEXYL)METHANONE METHANESULFONATE; [(2 METHYL 1,3 THIAZOL 4 YL)ETHYNYL]PYRIDINE; DIZOCILPINE; JNJ 16567083; METABOTROPIC RECEPTOR 1 ANTAGONIST; METABOTROPIC RECEPTOR 5 ANTAGONIST; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; FEAR; LEARNING; LONG TERM POTENTIATION; MALE; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; TRAINING;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); FEAR; LEARNING; LONG-TERM POTENTIATION; MALE; MODELS, BIOLOGICAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT (PSYCHOLOGY); STARTLE REACTION;

EID: 33344467243     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0249-3     Document Type: Article

References (44)

1. Aiba A, Chen C, Herrup K, Rosenmund C, Stevens CF, Tonegawa S (1994) Reduced hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR1 mutant mice. Cell 79:365-375
2. Attucci S, Carla V, Mannaioni G, Moroni F (2001) Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges. Br J Pharmacol 132:799-806
3. Balschun D, Wetzel W (2002) Inhibition of mGluR5 blocks hippocampal LTP in vivo and spatial learning in rats. Pharmacol Biochem Behav 73:375-380
4. Barros DM, Izquierdo LA, Mello e Souza T, Ardenghi PG, Pereira P, Medina JH, Izquierdo I (2000) Molecular signalling pathways in the cerebral cortex are required for retrieval of one-trial avoidance learning in rats. Behav Brain Res 114:183-192
5. Bashir ZI, Bortolotto ZA, Davies CH, Berretta N, Irving AJ, Seal AJ, Henley JM, Jane DE, Watkins JC, Collingridge GL (1993) Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature 363:347-350
6. Busse CS, Brodkin J, Tattersall D, Anderson JJ, Warren N, Tehrani L, Bristow LJ, Varney MA, Cosford ND (2004) The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl] pyridine (MTEP) in rodent models of anxiety. Neuropsychopharmacology 29:1971-1979
7. Campbell UC, Lalwani K, Hernandez L, Kinney GG, Conn PJ, Bristow LJ (2004) The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacology (Berl) 175:310-318
8. Campeau S, Miserendino MJ, Davis M (1992) Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus. Behav Neurosci 106:569-574
9. Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237
10. Danysz W, Wroblewski JT, Costa E (1988) Learning impairment in rats by N-methyl-D-aspartate receptor antagonists. Neuropharmacology 27:653-656
11. Danysz W, Zajaczkowski W, Parsons CG (1995) Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol 6:455-474
12. DeNoble VJ, Jones KW, Schaeffer CL, Bauerle LM (1990) 3-((+-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) and phencyclidine produce a deficit of passive avoidance retention in rats. Eur J Pharmacol 175:197-202
13. Fendt M, Schmid S (2002) Metabotropic glutamate receptors are involved in amygdaloid plasticity. Eur J Neurosci 15:1535-1541
14. Fujii S, Sasaki H, Mikoshiba K, Kuroda Y, Yamazaki Y, Mostafa Taufiq A, Kato H (2004) A chemical LTP induced by co-activation of metabotropic and N-methyl-D-aspartate glutamate receptors in hippocampal CA1 neurons. Brain Res 999:20-28
15. Gould TJ, McCarthy MM, Keith RA (2002) MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning. Behav Pharmacol 13:287-294
16. Gravius A, Pietraszek M, Schäfer D, Schmidt WJ, Danysz W (2005a) Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning. Behav Pharmacol 16:113-121
17. Gravius A, Pietraszek M, Schmidt WJ, Danysz W (2005b) Interaction of NMDA and group I metabotropic glutamate receptors in aversive learning. EBPS meeting, Barcelona, 2005
18. Homayoun H, Stefani MR, Adams BW, Tamagan GD, Moghaddam B (2004) Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release. Neuropsychopharmacology 29:1259-1269
19. Kim JJ, Fanselow MS (1992) Modality-specific retrograde amnesia of fear. Science 256:675-677
20. Kim M, McGaugh JL (1992) Effects of intra-amygdala injections of NMDA receptor antagonists on acquisition and retention of inhibitory avoidance. Brain Res 585:35-48
21. Kozela E, Pilc A, Popik P (2003) Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology (Berl) 165:245-251
22. Lan JY, Skeberdis VA, Jover T, Zheng X, Bennett MV, Zukin RS (2001) Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking. J Neurosci 21:6058-6068
23. Lee O, Lee CJ, Choi S (2002) Induction mechanisms for L-LTP at thalamic input synapses to the lateral amygdala: requirement of mGluR5 activation. Neuroreport 13:685-691
24. Lesage ASJ (2004) Role of group I metabotropic glutamate receptors mGlu1 and mGlu5 in nociceptive signalling. Current Neuropharmacology 2:363-393
25. Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, Wojtowicz JM, Roder JC (1997) Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci 17:5196-5205
26. Manahan-Vaughan D (1997) Group 1 and 2 metabotropic glutamate receptors play differential roles in hippocampal long-term depression and long-term potentiation in freely moving rats. J Neurosci 17:3303-3311
27. Miserendino MJ, Sananes CB, Melia KR, Davis M (1990) Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345:716-718
28. Moroni F, Lombardi G, Thomsen C, Leonardi P, Attucci S, Peruginelli F, Torregrossa SA, Pellegrini-Giampietro DE, Luneia R, Pellicciari R (1997) Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J Pharmacol Exp Ther 281:721-729
29. Morris RGM, Anderson E, Lynch GS, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319:774-776
30. Musgrave MA, Ballyk BA, Goh JW (1993) Coactivation of metabotropic and NMDA receptors is required for LTP induction. Neuroreport 4:171-174
31. Naie K, Manahan-Vaughan D (2004) Regulation by metabotropic glutamate receptor 5 of LTP in the dentate gyrus of freely moving rats: relevance for learning and memory formation. Cereb Cortex 14:189-198
32. Nielsen KS, Macphail EM, Riedel G (1997) Class I mGlu receptor antagonist 1-aminoindan-1,5-dicarboxylic acid blocks contextual but not cue conditioning in rats. Eur J Pharmacol 326:105-108
33. Nishiyama T (2000) Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia. Can J Anaesth 47:693-698
34. Parsons CG, Danysz W, Quack G (1998) Glutamate in CNS disorders as a target for drug development. An update. Drug News Perspect 11:523-569
35. Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106:274-285
36. Pietraszek M, Sukhanov I, Maciejak P, Szyndler J, Gravius A, Wisłowska A, Płaźnik A, Bespalov AY, Danysz W (2005) Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur J Pharmacol 514:25-32
37. Pin JP, Acher F (2002) The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Curr Drug Targets CNS Neurol Disord 1:297-317
38. Schulz B, Fendt M, Gasparini F, Lingenhohl K, Kuhn R, Koch M (2001) The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology 41:1-7
39. Sevostianova N, Danysz W (2005) The modulation of nociception by group I metabotropic glutamate receptor antagonists in rats. Program No. 292.15. Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC
40. Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, Schreiber R (2003) Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. Behav Pharmacol 14:257-277
41. Steckler T, Oliveira AF, Van Dyck C, Van Craenendonck H, Mateus AM, Langlois X, Lesage AS, Prickaerts J (2005a) Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial water maze task. Behav Brain Res 164:52-60
42. Steckler T, Aerts N, Van Craenendonck H, Lavreysen H, Meert T, Lesage A (2005b) Effecls of mGlu1 receptor antagonism on anxiety - related behaviour in the rat lick suppression test. Psychopharmacology 179:198-206
43. Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, Flor PJ, Vranesic I, Lingenhoehl K, Johnson EC, Varney M, Urban L, Kuhn R (2001) Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology 40:1-9
44. Zajaczkowski W, Frankiewicz T, Parsons CG, Danysz W (1997) Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP. Neuropharmacology 36:961-971